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Assessing the regulation of Clostridium difﬁcile transferase (CDT), is complicated by the presence of a
Pathogenicity locus (PaLoc) which encodes Toxins A and B. Here we developed R20291DPaLoc model
strains and cell-based assays to quantify CDT-mediated virulence. Their application demonstrated that
the transcriptional regulator, CdtR, was required for CDT-mediated cytotoxicity.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Clostridium difﬁcile infection (CDI) is the leading cause of hos-
pital associated diarrhoea in the developed world. In 2011, there
were an estimated 453,000 cases and 29,000 deaths in the USA
alone [1]. The main virulence factors of C. difﬁcile are Toxin A (TcdA)
and Toxin B (TcdB) whose genes reside on a 19.6 Kb pathogenicity
locus (PaLoc) [2]. Some hypervirulent strains responsible for out-
breaks and severe cases of disease, in particular BI/NAP1/027
strains including the archetypal strain R20291, produce an addi-
tional toxin, the binary toxin or Clostridium difﬁcile transferase
(CDT) [3]. Owing to the overwhelming potency of TcdA and TcdB, it
is difﬁcult to study the genetic regulation of CDT using cell-based
assays or in vivo approaches. Moreover, the main approach forup, BBSRC/EPSRC Synthetic
ces, Centre for Biomolecular
NG7 2RD, UK.
.P. Minton).
ool of Dentistry, College of
ngham, Birmingham, B5 7EG,
r Ltd. This is an open access articleaccurately quantifying CDT is through ADP-ribosyltransferase as-
says which utilise radioactive phosphorus 32 and require adher-
ence to stringent safety precautions, although, a prototypal ELISA
assay reliant on an antibody against the B subunit of the Clostridium
perfringens Iota Toxin, has also been described [4]. In light of these
impediments, the regulation of CDT remains relatively uncharac-
terised. However, a gene encoding the transcriptional regulator
CdtR belonging to the LytTR family, was discovered upstream of
cdtA and cdtB (for locus arrangement see Fig. S1b), and was shown
to be required for the maximal expression of CDT [5]. By intro-
ducing CDT on autonomous plasmids to strains which lack the
toxin, with or without the cdtR gene, the presence of cdtR was
shown to increase CDT production by 17-fold [5].
The development of model strains devoid of TcdA and TcdB
activity, coupled with reliable in vitro cell-based assays for the
quantiﬁcation of CDT, would facilitate the study of CDT regulation.
We used allelic exchange technology, to delete the entire protein-
coding region of the PaLoc in the PCR-Ribotype 027 strain R20291
in which the pyrE gene had been deleted to facilitate genome en-
gineering [6]. Deletion of the PaLoc has not been previouslyunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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reported to date. We achieved this by the construction of a
knockout cassette homologous to the regions up/downstream of
the PaLoc. The cassette was conjugated into C. difﬁcile from E. coli
CA434 and gene deletion was achieved through two homologous
recombination events [7]. In addition, we used the same method-
ology to make the ﬁrst reported in-frame deletion mutant for cdtR.
The mutant created was designated R20291DpyrEDcdtR. We also
made triple mutants in which pyrE, cdtR and the PaLoc had all been
deleted. Gene deletions were authenticated by PCR of the target
regions (see supplementary material) using the appropriate
primers (Table S2). Following the authentication of the deletion
mutants, the pyrE allele was repaired in strains R20291Dpyr-
EDPaLoc and R20291DpyrEDPaLocDcdtR using the plasmid pMTL-
YN2 [6]. In parallel, cdtR along with the 273bp upstream region
encompassing its native promoter, was cloned into pMTL-YN2C [6],
which was used to simultaneously repair pyrE, and integrate the
promoter-cdtR construct into the genome at the pyrE locus to
generate the complemented strain R20291DPaLocDcdtR*cdtR.
To validate the TcdA/B minus phenotype of the constructed
model strains, the combined concentration of TcdA and TcdB was
quantiﬁed in 48 h supernatants from 4 replicate cultures per
strain, by ELISA. No toxins could be detected in the supernatant of
any of the tested clones and they were indistinguishable from the
PBS controls (Fig. 1a). The parental strain R20291 secreted
approximately 4200 ng/ml combined TcdA and TcdB. In addition,Fig. 1. (a) Concentration of combined TcdA and TcdB detected in the supernatants of the D
mean ± SD of 4 replicate values. P¼<0.0001 as determined by one-way ANOVA followed
concentrations of combined TcdA and TcdB from 0 to 125 ng/ml was 0.9955 and the followi
0.0205 after accounting for the initial dilutions. (b) Cytotoxicity assay using Vero cells treated
point represents the greatest dilution at which >50% of the cells had rounded. Data represen
48 h supernatants from the DPaLoc model strains and wild-type controls. Data represent the
way ANOVA followed by Dunnett's multiple comparison test. (d) Representative image of a
Representative image of a Vero cell monolayer treated with a 1  10-1 dilution of R20291the absence of TcdA and TcdB was conﬁrmed through cytotoxicity
assays using Vero cells (kidney cells from the African green mon-
key) with 24 h and 48 h supernatants. At the 24 h and 48 h time
point, the R20291 supernatant rounded >50% of the cells down to a
1  104 and 1  105 dilution, respectively (Fig. 1b and c). In
contrast, supernatants derived from the model strains in which the
PaLoc had been deleted, caused no cell rounding at any of the di-
lutions (1  101 e1  108) tested (Fig. 1b and c) at the same time
points. Fig. 1d and e, are representative images of Vero cells treated
with a 101 dilution of the supernatants of strains R20291DPaLoc
and R20291, respectively. A conﬂuent monolayer of healthy cells is
visible in the former image whereas all of the cells had clearly
rounded in the latter image.
Following validation of the TcdA/B minus phenotype, we
investigated CDT production and tested the effects of cdtR deletion.
Our initial assessments relied on Western blot procedures using an
antibody against the enzymatic subunit of CDT, CdtA. Supernatants
were collected and processed at 48 h and 96 h time points from
R20291, R20291DPaLoc and R20291DPaLocDcdtR. Distinct 48 kDa
bands were detectable across both time points for R20291 and
R20291DPaLoc (Fig. 2). However, no distinct bands were detected
from the supernatants of strain R20291DPaLocDcdtR. This indicated
that without functional CdtR, CdtA production was either
completely ablated, or its production was reduced to concentra-
tions below the detection threshold of the antibody. Deletion of the
PaLoc appeared to have no discernible effect on CDT production.PaLoc model strains and wild-type controls, as assessed by ELISA. Data represent the
by Dunnett's multiple comparison test. The R2 value determined by assaying known
ng equation was used to convert absorbance values to toxin concentrations (x-0.1015)/
with 24 h supernatants from the DPaLoc model strains and wild-type controls. The end
t the mean ± SD of 5 replicate values. (c) Cytotoxicity assay using Vero cells treated with
mean ± SD of 4 replicate values. P ¼ ***<0.0002, ****<0.0001 as determined by one-
Vero cell monolayer treated with a 1  10-1 dilution of R20291DPaLoc supernatant. (e)
supernatant.
Fig. 2. Western blot of 48 and 96 h supernatants detected with an anti-CdtA:HRP
antibody derived from strains R20291, R20291DPaLoc, R20291DcdtRDPaLoc and
R20291DcdtRDPaLoc*cdtR.
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of CdtA (Fig. 2). In fact, the R20291DPaLocDcdtR*cdtR strain
appeared to overexpress the phenotype. An insertional mutant has
recently been generated for cdtR, and in that study, residual CdtA
was clearly detectable by Western blot following gene interruption
[8]. However, owing to the nature of group II intron insertional
mutagenesis, the residual expression may be a polar effect from the
promoter of the erythromycin resistance marker since the authors
describe an antisense insertion [8].
The glucosylation of Rho family GTPAses by TcdA and TcdB, leads
to cytoskeletal disorganisation and consequently cell rounding [9].
This forms the basis of cytotoxicity assays for the quantiﬁcation of
TcdA and TcdB. CdtA, ADP-ribosylates monomeric actin, leading to
actin depolymerisation and consequently cell rounding [10]. With
the masking effects of TcdA and TcdB removed, it should now be
possible to measure the cytotoxic effects of CDT in model strain-
derived supernatants. Before doing so, the CdtB binding subunit
of CDT requires activation by proteolytic cleavage. Without which,
CdtA cannot be taken up into mammalian cells [11,12]. An effective
strategy for achieving this was established by the treatment ofFig. 3. (a) Total number of rounded cells (b) Percentage of rounded cells relative to comple
relative controls. Data represent the mean ± SD of ﬁve replicate values P ¼<0.0001 as detesupernatants with 400 mg/ml trypsin and its subsequent inhibition
with 200 mg/ml trypsin inhibitor (see Supplementary Material).
Following CDT activation, model strain-derived supernatants were
diluted in a 4-fold series and were applied to monolayers of Vero
cells.
To determine the cytotoxicity of the supernatants, the total
number of rounded cells was determined from images of cells
treated with undiluted supernatants of each replicate culture per
strain (n ¼ 5). Since the well-plate was seeded with the same
density of Vero cell suspension, and each replicate bacterial culture
was normalised to the same OD (0.135), there shouldn't be any
major difference in the total number of cells, or number of rounded
cells between conditions, other than in response to virulence fac-
tors in the supernatant. On visualisation of the cells treated with
supernatants derived from R20291DPaLoc, practically all of the
cells had rounded (Fig. S3aec). An average of 268 rounded cells
were counted, representing the 100% rounded cell benchmark, i.e.
complete cytotoxicity (Fig. 3). An average of 25.6 rounded cells
were detected in the monolayers treated with the R20291DPa-
LocDcdtR supernatant (Fig. S3def), corresponding to only 9.6% of
the cytotoxic effect of R20291DPaLoc (Fig. 3). This residual toxicity,
however, was not CDT-mediated, since the CDT-minus control
comprising R20291DPaLoc supernatant without the proteolytic
activation of CdtB, and which consequently could not mediate
cellular entry of CdtA [11,12], also led to an average of 25.6 rounded
cells (Fig. S3jl), thus demonstrating the involvement of other non-
toxin virulence factors. Owing to variation between samples, this
represented 9.54% of the relative cytotoxicity of the R20291DPaLoc
supernatant (Fig. 3). Supernatants derived from the complemented
strain R20291DPaLocDcdtR*cdtR rounded an average of 264 cells
(Fig S3mo), which is 1.6% fewer cells than observed for the
R20291DPaLoc supernatant (Fig. 3). For the trypsin control (sterile
PBS treated with trypsin and subsequently trypsin inhibitor),
(Fig. S3gi), only 4.6 cells had rounded, representing 1.7% of the
relative cytotoxicity of R20291DPaLoc (Fig. 3). Trypsinisation and
trypsin inhibition therefore, was not adversely affecting the cells.te virulence by strain R20291DPaLoc, for Vero cells treated with the model strains and
rmined by one-way ANOVA followed by Dunnett's multiple comparison test.
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cells compared with the trypsin control for the supernatants of
strains R20291DPaLoc and R20291DPaLocDcdtR. However, the
R20291DPaLocDcdtR*cdtR-derived supernatant still rounded all of
the cells at this dilution (Fig. S4), thus indicating that the expression
of cdtR is at least 4-fold higher than the parental strain. These data
suggest that, within the parameters tested, CdtR is required for the
production of CDT to levels which are cytotoxic towards Vero cell
lines, thus demonstrating the importance of this transcriptional
regulator.
In summary, we have developed model strains for the study of
CDT without interference from TcdA and TcdB and demonstrated
their utility. We have coupled them with cytotoxicity assays using
Vero cell lines, to develop a reproducible method for studying the
regulation of CDT. This was achieved by comparative assessment of
the CDT-mediated virulence of genetic mutants, in our case
R20291DPaLocDcdtR, with the control strain R20291DPaLoc.
Application of the model strains and cytotoxicity assays, conﬁrmed
the role of CdtR in CDT production. The availability of these strains
will facilitate the discovery and analysis of those determinants
involved not only in CDT production, but also other non-toxin,
secreted virulence factors.
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